Two board appointments at EyeGate Pharma
This article was originally published in Scrip
Executive Summary
EyeGate Pharma (US) has appointed Paul Chaney chairman of the board and Dr Morton Goldberg as director. Mr Chaney is a consultant at Eyetech, which recently spun out of (OSI) Eyetech, OSI's eye care subsidiary. He was previously executive vice-president of OSI Pharmaceuticals and president of (OSI) Eyetech. Dr Goldberg is a Joseph E Green professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.